IP Group’s portfolio company Microbiotica completes £50m fund raise
LONDON, UK: IP Group plc (LSE: IPO) portfolio company Microbiotica Ltd, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, has completed its...
Arix Bioscience founds new portfolio company, Twelve Bio
LONDON: Arix Bioscience Plc, a global venture capital company focused on investing in and building breakthrough biotech companies, announced the foundation of a new portfolio...